DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
VCs Invest $23M In Roche Holding Spinout Afferent Pharmaceuticals
News | 12. 16. 2009
Afferent Pharmaceuticals
Venture firms are investing $23 million to spin out a start-up from Roche Holding Ltd. that plans to attack chronic pain in a new way.
